Net earnings attributable to UnitedHealth Group common
shareholders was $3.5 billion, or $3.58 per share, compared to $3 billion, or $3.10
per share, last year. Adjusted EPS grew 19% to $3.90, beating estimates of
$3.28.
Favorable medical reserve development was $270 million in the quarter, with $150 million related to 2019 and $120 million related to previous years. Year-end days claims payable were 50.8 days compared to 49.5 in the fourth quarter of 2018. Medical costs increased 8% in the period.
Also read: BlackRock Q4 2019 Earnings Snapshot
ADVERTISEMENT
During the quarter, revenues in the UnitedHealthcare segment
increased 4% to $48.2 billion versus the prior-year period. Revenues in the
Optum segment increased 7% year-over-year to $29.8 billion.
Revenues from premiums increased 6%. Revenues from products
decreased slightly during the quarter while services revenues increased.
Revenues from investment and other income rose 26%.
For the full year of 2020, GAAP EPS is expected to be $15.45 to $15.75 and adjusted EPS is expected to be $16.25 to $16.55.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.